Han Joo Chae, PhD
Han Joo Chae, PhD, is Chief Technology Officer at Oncosoft, where he leads the development of AI-driven software that makes radiotherapy safer, more precise, and adaptive. A specialist in computer vision and machine learning, he turns cutting-edge research into regulatory-ready clinical tools.
Prior to Oncosoft, Dr. Chae was CTO of Kai Health, delivering AI solutions for personalized fertility care, and Chief AI Officer at ROKIT Healthcare, where he created an AI-enabled 3D-bioprinting platform that helped secure more than $1 billion in long-term contracts for personalized-medicine devices. Earlier, he refined user-centric design as a UX researcher at Samsung Electronics and explored augmented-reality interfaces during his doctoral studies.
His scholarship includes a flagship CVPR paper on generating 3D bio-printable wound patches for diabetic-foot-ulcer treatment and an ICME paper advancing neural RGB-D surface reconstruction. Dr. Chae earned his PhD in Computer Science and Engineering from Seoul National University and MS/BS degrees in Electrical and Computer Engineering from Carnegie Mellon University.
He has authored numerous peer-reviewed papers and holds multiple U.S. patents. Committed to clinical impact, he collaborates closely with radiation oncologists and global cloud providers so that every line of code improves patient outcomes.
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none